Page last updated: 2024-10-24

chlorambucil and Mouth Diseases

chlorambucil has been researched along with Mouth Diseases in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Mouth Diseases: Diseases involving the MOUTH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boras, VV1
Židovec-Lepej, S1
Marinović, B1
Seiwerth, S1
Škrinjar, I1
Pulanić, D1
Juras, DV1

Other Studies

1 other study available for chlorambucil and Mouth Diseases

ArticleYear
DRUG-INDUCED ORAL ULCERATIONS: CASE REPORT.
    Acta clinica Croatica, 2016, Volume: 55, Issue:2

    Topics: Aged; Allopurinol; Antineoplastic Agents, Alkylating; Chlorambucil; Free Radical Scavengers; Humans;

2016